Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.80
-0.29 (-3.19%)
At close: Mar 17, 2026, 4:00 PM EDT
9.12
+0.32 (3.64%)
After-hours: Mar 17, 2026, 5:18 PM EDT
Kyverna Therapeutics Employees
Kyverna Therapeutics had 129 employees as of September 30, 2025. The number of employees increased by 10 or 8.40% compared to the same quarter last year.
Employees
129
Change
10
Growth
8.40%
Revenue / Employee
n/a
Profits / Employee
-$1,248,000
Market Cap
385.41M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 129 | 10 | 8.40% |
| Jun 30, 2025 | 129 | 17 | 15.18% |
| Mar 31, 2025 | 119 | 19 | 19.00% |
| Dec 31, 2024 | 112 | 16 | 16.67% |
| Sep 30, 2024 | 119 | 30 | 33.71% |
| Jun 30, 2024 | 112 | 23 | 25.84% |
| Mar 31, 2024 | 100 | - | - |
| Dec 31, 2023 | 96 | - | - |
| Sep 30, 2023 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Ginkgo Bioworks Holdings | 485 |
| Absci | 157 |
| Niagen Bioscience | 117 |
| Lineage Cell Therapeutics | 77 |
| Larimar Therapeutics | 65 |
| PureTech Health | 56 |
| Zura Bio | 30 |
KYTX News
- 4 days ago - Kyverna Therapeutics, Inc. (KYTX) Presents at Leerink Global Healthcare Conference 2026 Transcript - Seeking Alpha
- 12 days ago - Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026 - GlobeNewsWire
- 14 days ago - Kyverna Therapeutics to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 15 days ago - Kyverna Therapeutics: The King Of The CAR-T Autoimmune Revolution - Seeking Alpha
- 21 days ago - Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors - GlobeNewsWire
- 6 weeks ago - Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer - GlobeNewsWire
- 2 months ago - Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire